0,938  0,004  Antineoplastic (breast cancer)
0,926  0,002  Sensitization
0,926  0,004  Antineoplastic (non-small cell lung cancer)
0,920  0,004  Antineoplastic (melanoma)
0,921  0,005  Transcription factor NF kappa B inhibitor
0,916  0,004  Antineoplastic (colorectal cancer)
0,914  0,004  Antineoplastic (colon cancer)
0,900  0,003  Antineoplastic (carcinoma)
0,888  0,007  Apoptosis agonist
0,880  0,004  Cytostatic
0,871  0,005  Antileukemic
0,866  0,008  Antiinflammatory
0,859  0,005  Antineoplastic (lung cancer)
0,855  0,003  Antineoplastic (squamous cell carcinoma)
0,838  0,004  Nitric oxide antagonist
0,811  0,004  Cardiovascular analeptic
0,781  0,005  Antineoplastic (ovarian cancer)
0,776  0,005  Analeptic
0,739  0,007  Prostate cancer treatment
0,687  0,005  Immunosuppressant
0,684  0,007  Antineoplastic (cervical cancer)
0,667  0,005  Antineoplastic (multiple myeloma)
0,655  0,005  Antineoplastic (glioma)
0,645  0,009  Cytotoxic
0,629  0,007  Apoptosis antagonist
0,624  0,016  Antibacterial
0,611  0,010  Antineoplastic (pancreatic cancer)
0,595  0,005  Antineoplastic (sarcoma)
0,597  0,012  Proliferative diseases treatment
0,586  0,005  Antineoplastic (liver cancer)
0,577  0,004  ICAM1 expression inhibitor
0,584  0,012  Hepatic disorders treatment
0,581  0,012  Antiparasitic
0,564  0,007  Antineoplastic (lymphoma)
0,542  0,009  Antineoplastic (glioblastoma multiforme)
0,527  0,017  Antifungal
0,535  0,029  Teratogen
0,522  0,018  Chemopreventive
0,527  0,030  Antiprotozoal
0,507  0,012  Antimitotic
0,509  0,016  Antiprotozoal (Leishmania)
0,494  0,005  Platelet adhesion inhibitor
0,518  0,038  CYP3A4 substrate
0,489  0,010  Antihelmintic
0,489  0,012  Antineoplastic (osteosarcoma)
0,485  0,009  Antiulcerative
0,496  0,021  AR expression inhibitor
0,483  0,008  Hepatoprotectant
0,481  0,008  Transcription factor STAT3 inhibitor
0,482  0,011  Antineoplastic (renal cancer)
0,500  0,031  Embryotoxic
0,445  0,005  Protein kinase stimulant
0,463  0,025  Antioxidant
0,446  0,028  Carcinogenic
0,449  0,036  Respiratory analeptic
0,434  0,023  Hypoglycemic
0,467  0,056  TNF expression inhibitor
0,423  0,015  Transcription factor STAT inhibitor
0,423  0,019  DNA synthesis inhibitor
0,417  0,013  Contraceptive
0,419  0,019  Antineoplastic (endocrine cancer)
0,437  0,039  Antiprotozoal (Plasmodium)
0,379  0,006  Antifungal enhancer
0,421  0,056  Antineoplastic (myeloid leukemia)
0,444  0,083  Antineoplastic (solid tumors)
0,387  0,034  NOS2 expression inhibitor
0,352  0,014  Interferon gamma antagonist
0,375  0,046  Antineoplastic (brain cancer)
0,344  0,015  Tubulin antagonist
0,396  0,068  Antipruritic, allergic
0,362  0,034  Mutagenic
0,339  0,017  VCAM1 expression inhibitor
0,357  0,036  Tumour necrosis factor alpha release inhibitor
0,317  0,009  Antineoplastic antibiotic
0,339  0,032  Antineoplastic (lymphocytic leukemia)
0,366  0,060  Bone diseases treatment
0,318  0,017  Hair growth stimulant
0,293  0,005  T cell inhibitor
0,308  0,021  Antiacne
0,298  0,017  Antiviral (Influenza A)
0,297  0,018  Sepsis treatment
0,297  0,019  Prostate disorders treatment
0,275  0,004  Microtubule formation inhibitor
0,295  0,028  UGT2B7 substrate
0,300  0,035  Abortion inducer
0,324  0,059  Sodium/bile acid cotransporter inhibitor
0,270  0,007  Antifungal (Cryptococcus)
0,323  0,064  NOS3 expression inhibitor
0,314  0,058  Antihypercholesterolemic
0,289  0,041  Antihypertriglyceridemic
0,263  0,021  Interleukin 6 antagonist
0,266  0,025  Carcinogenic, group 3
0,274  0,037  Antiviral (Influenza)
0,226  0,007  Aromatase inhibitor
0,289  0,073  5 Hydroxytryptamine release stimulant
0,284  0,069  UGT2B4 substrate
0,277  0,065  Antipyretic
0,229  0,020  ATPase inhibitor
0,241  0,032  Antineoplastic (gastric cancer)
0,269  0,061  Free radical scavenger
0,213  0,008  Actinic keratosis treatment
0,275  0,078  Antiosteoporotic
0,222  0,029  UGT2B9 substrate
0,215  0,023  Cholesterol synthesis inhibitor
0,202  0,019  Interleukin 1b antagonist
0,227  0,045  Antipruritic, non-allergic
0,196  0,018  Growth stimulant
0,183  0,006  Ca2+-transporting ATPase inhibitor
0,280  0,105  Cholesterol antagonist
0,204  0,030  Arachidonic acid antagonist
0,194  0,023  Carcinogenic, group 2B
0,228  0,057  UDP-glucuronosyltransferase substrate
0,276  0,106  Antithrombotic
0,214  0,048  Lipocortins synthesis antagonist
0,171  0,009  Anabolic
0,263  0,105  Interleukin 2 agonist
0,253  0,095  Cardioprotectant
0,159  0,006  Glycine receptor agonist
0,201  0,048  Liver fibrosis treatment
0,258  0,109  CYP3A4 inhibitor
0,320  0,172  Caspase 9 stimulant
0,222  0,074  Peptidyltransferase inhibitor
0,228  0,084  Vasodilator
0,187  0,047  Melanin inhibitor
0,190  0,051  Antirickettsial
0,207  0,068  Pneumotoxic
0,188  0,053  Toxic, respiratory center
0,152  0,019  Antibiotic
0,151  0,020  CC chemokine 6 receptor antagonist
0,134  0,012  ATPase (Vacuolar H+) inhibitor
0,196  0,075  UGT1A1 substrate
0,133  0,012  Glycine receptor antagonist
0,223  0,104  Spasmolytic
0,151  0,033  Contraceptive female
0,144  0,029  Antineoplastic alkaloid
0,207  0,096  Platelet antagonist
0,165  0,055  Genotoxic
0,179  0,069  Muscle relaxant
0,123  0,015  Na+ K+ transporting ATPase inhibitor
0,234  0,127  Caspase 3 stimulant
0,182  0,078  P-glycoprotein inhibitor
0,217  0,115  Chemoprotective
0,170  0,068  UGT2B10 substrate
0,209  0,115  Immunostimulant
0,156  0,065  UGT2B15 substrate
0,169  0,079  Antineoplastic (bone cancer)
0,114  0,025  Contraceptive male
0,214  0,132  Antihypoxic
0,169  0,089  Sedative
0,093  0,015  Protein 50S ribosomal subunit inhibitor
0,155  0,081  Antihelmintic (Nematodes)
0,150  0,078  Antiviral (Herpes)
0,195  0,127  Lipoprotein disorders treatment
0,075  0,009  RNA-directed RNA polymerase stimulant
0,083  0,017  Hypercalcemia treatment
0,077  0,013  Potassium channel Kv1.3 blocker
0,078  0,015  Postcoital contraceptive
0,083  0,021  Antimycoplasmal
0,066  0,009  Microtubule stabilization
0,112  0,058  Electron transport complex I inhibitor
0,130  0,076  Interleukin 1 antagonist
0,071  0,020  Lipocortins synthesis agonist
0,080  0,031  HIV-1 integrase (Strand Transfer) inhibitor
0,227  0,182  Antineoplastic (small cell lung cancer)
0,113  0,068  Estrogen antagonist
0,069  0,027  Postmenopausal disorders treatment
0,100  0,058  UGT2B11 substrate
0,054  0,016  Parathyroid hormone antagonist
0,137  0,100  Prostatic (benign) hyperplasia treatment
0,093  0,057  Thioredoxin inhibitor
0,065  0,028  Estrogen agonist
0,079  0,044  Lipase inhibitor
0,113  0,078  Alcohol dehydrogenase substrate
0,161  0,126  Hypolipemic
0,087  0,054  Antispirochetal
0,100  0,069  Expectorant
0,200  0,169  Angiogenesis inhibitor
0,124  0,096  Farnesoid X receptor antagonist
0,129  0,102  Pregnane X receptor agonist
0,085  0,059  Transcription factor NF kappa B stimulant
0,190  0,164  Hypoxia-inducible factor 1 alpha inhibitor
0,144  0,119  LDLR expression enhancer
0,063  0,038  Androgen agonist
0,045  0,021  5-Alpha-reductase inhibitor
0,128  0,104  UGT1A3 substrate
0,040  0,015  Tubulin agonist
0,127  0,103  NOS3 expression enhancer
0,098  0,074  UGT2B1 substrate
0,030  0,007  Vitamin D receptor antagonist
0,128  0,106  Adenylate cyclase stimulant
0,125  0,106  Eye irritation, high
0,076  0,060  Chymotrypsin inhibitor
0,086  0,072  UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor
0,041  0,030  Hypogonadism treatment
0,114  0,104  Vanilloid 1 agonist
0,020  0,012  Progesterone receptor B antagonist
0,053  0,045  Beta tubulin antagonist
0,027  0,019  Retinoid X gamma receptor antagonist
0,093  0,086  Protein-tyrosine phosphatase 1B inhibitor
0,032  0,028  HMG CoA reductase inhibitor
0,117  0,114  UGT1A4 substrate
0,070  0,067  Narcotic antagonist
0,013  0,010  Antibiotic Macrolide-like
0,064  0,063  SULT2A1 substrate
0,075  0,074  Antiprotozoal activity enhancer

